Leaderboard

En | De
No articles selected!     View Cart  
You are here: Psychiatry » Schizophrenia and Psychotic Disorders 27. October 2026
Search
medline.ch
Schizophrenia and Psychotic Disorders
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Anxiety Disorders
Dementia
Depressive Disorders
Eating Disorders
Personality Disorders
Schizophrenia and Psychotic Disorders
Sleep Disorders
Sexual Disorders
Somatoform Disorders
Substance-Related Disorders
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 3509  Previews Next
   
   Articles 1 - 20 / 70169  
   
Neurobiological insights into psychotic depression from magnetic resonance imaging: a systematic review.
J Psychiatry Neurosci
Ming Y, Zhang Q, Zhang A, Zhang X, Li Q, Zhang H, Kemp G, Zhao Y.
PMID: 42945133 [PubMed - indexed for MEDLINE]


The LAI-Oral Antipsychotic Efficacy-Effectiveness Paradox in Schizophrenia.
Medicina (Kaunas)
Stoychev K, Begum S, Nazar S.
PMID: 42942491 [PubMed - indexed for MEDLINE]


A Clinical Perspective on Multidimensional Assessment of Clinical High-Risk States for Psychosis Beyond Transition Prediction.
J Clin Med
Vasiliu O, Marinescu I, Mangalagiu AG, Petrescu BM, Ciobanu AM.
PMID: 42941470 [PubMed]


Machine Learning Based on Routine Hematological Parameters and Derived Inflammatory Indices for the Diagnosis of Schizophrenia.
Biomedicines
Fu X, Jin W, Li D, Li Z, Chen Q, Chen S, Ma P, Zhu M, Wang M, Qu C, Pan R, Chai Z, Lin P.
PMID: 42940015 [PubMed]


N-Acetylcysteine in Schizophrenia: A Convergent Redox-Based Approach to Therapeutic Potential.
Antioxidants (Basel)
Rubio-Contreras E, Pérez-Toribio A, Álvaro P, Cosialls AM, Morén C.
PMID: 42939851 [PubMed]


Serum Melatonin at Admission and Discharge in Schizophrenia: A Prospective Longitudinal Controlled Study.
Biomolecules
Morera-Fumero AL, Diaz-Mesa E, Yelmo-Cruz S, Abreu-González P, Fernández-López ML.
PMID: 42939692 [PubMed - indexed for MEDLINE]


From Insulin Resistance to Mitochondrial Failure: A Staged Model of Impaired Metabolic Flexibility in Schizophrenia.
Biomolecules
Cubitt M, Ellenbroek B, Haase AM.
PMID: 42939652 [PubMed - indexed for MEDLINE]


Effects of Second-Generation Long-Acting Injectable Antipsychotics on Brain Structure in Schizophrenia: A Systematic Review of Neuroimaging Studies.
Brain Sci
Martiadis V, Scognamiglio P, Raffone F, Olivola M, Iniziato V, Barlattani T, Pacitti F, De Berardis D.
PMID: 42939274 [PubMed]


Psychedelics and psychosis: A systematic review of recent-era studies (1984-2025).
J Psychopharmacol
Reis JAS, Ueta LZ, Bouso JC, Hallak JEC, Dos Santos RG.
PMID: 42937077 [PubMed - as supplied by publisher]


A narrative review of research status and prospects of mindfulness-based interventions in schizophrenia.
Front Psychol
Xin J, Zhu J, Lu H.
PMID: 42936520 [PubMed]


Real-world associations of antipsychotic use with clinical outcomes in schizophrenia: a systematic review and meta-analysis.
Mol Psychiatry
Yao H, Peng Z, Huang Y, Wu R.
PMID: 42934261 [PubMed - as supplied by publisher]


Dual immune dysregulation in adolescent-onset schizophrenia: attenuated B cell trophic support and elevated IL-23/Th17 inflammation are diagnostic and clinical biomarkers.
Transl Psychiatry
Yang H, Luan L, Han Y, Li S, Yang M, Zhang X.
PMID: 42934216 [PubMed - indexed for MEDLINE]


Effects of an Occupation-Based Group Occupational Therapy Intervention on Cognitive Functioning in Adults with Schizophrenia: A Randomized Controlled Trial.
Neurol Int
Stratou E, Athanasopoulou C, Koinis A, Porfyri GN, Daskalou SD, Gerosideris N, Arvanitidou E, Gamvroula A, Pierrakos G, Katsouri IG.
PMID: 42931136 [PubMed]


Effect of Internalized Stigma on Disability in Individuals With Schizophrenia and Bipolar Disorder: A Comparative Study.
Int J Soc Psychiatry
Datta A, Chetia D.
PMID: 42929435 [PubMed - as supplied by publisher]


Longitudinal changes in cognitive biases mediate the association between stress exposure and psychotic-like experiences: Findings from a general population study.
Psychol Med
Karska J, Misiak B.
PMID: 42929238 [PubMed - indexed for MEDLINE]


Indirect moxibustion therapy improves insomnia and associated symptoms in patients with schizophrenia.
Trials
Cai J, Wu M, Zhang J.
PMID: 42928360 [PubMed - indexed for MEDLINE]


Performance and response time in emotion recognition and mentalizing measures in patients with schizophrenia.
BMC Psychiatry
Ruiz-Toca A, Hernández-Gómez A, Andrade-González N, Fernández-Aragón C, Stiles BJ, Fernandez-Egea E, Rodriguez-Jimenez R, Lahera G.
PMID: 42928192 [PubMed - indexed for MEDLINE]


Moving towards evidence-based screening and investigations in first episode psychosis: A commentary on the ANZJP GRADE Schizophrenia Guidelines.
Aust N Z J Psychiatry
Chalmers K, Laurie K, Nitz M, Debattista J, Parker S.
PMID: 42926310 [PubMed - as supplied by publisher]


Serum metabolic characteristics and potential biomarkers of first-episode schizophrenia: An exploratory machine learning-based metabolomics study.
Prog Neuropsychopharmacol Biol Psychiatry
Peng XQ, Liu B, Meng W, Huang J, Zhang Q, Chen L, Li K, Tong HHY, Zhang X, Zhang J, Rao WW.
PMID: 42925955 [PubMed - as supplied by publisher]


Efficacy and safety of GLP-1 receptor agonists in patients with schizophrenia spectrum disorders treated with antipsychotics: a systematic review and meta-analysis.
Eur Neuropsychopharmacol
G, Modrzejewski S, Pola, Wa, Molero P, Wichniak A, Dominiak M, McIntyre RS.
PMID: 42925811 [PubMed - as supplied by publisher]


   
   Articles 1 - 20 / 70169    Page 1 of 3509  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1